Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)
24.02
-0.25 (-1.03%)
At close: Mar 9, 2026
SHA:688163 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 2,695 | 2,356 | 1,900 | 2,163 | 2,282 | - | Upgrade
|
| Market Cap Growth | 38.64% | 23.97% | -12.16% | -5.22% | - | - | Upgrade
|
| Enterprise Value | 1,912 | 1,574 | 1,053 | 1,312 | 1,366 | - | Upgrade
|
| Last Close Price | 24.90 | 21.77 | 17.29 | 19.23 | 19.67 | - | Upgrade
|
| PE Ratio | 51.88 | 45.56 | 42.91 | 55.79 | 35.55 | - | Upgrade
|
| PS Ratio | 13.73 | 12.01 | 9.75 | 11.38 | 13.10 | - | Upgrade
|
| PB Ratio | 2.40 | 2.09 | 1.74 | 1.99 | 2.04 | - | Upgrade
|
| P/TBV Ratio | 2.44 | 2.14 | 1.77 | 2.04 | 2.08 | - | Upgrade
|
| P/FCF Ratio | - | - | - | 521.89 | 55.06 | - | Upgrade
|
| P/OCF Ratio | - | - | 37.82 | 65.92 | 33.61 | - | Upgrade
|
| EV/Sales Ratio | 9.75 | 8.02 | 5.40 | 6.90 | 7.84 | - | Upgrade
|
| EV/EBITDA Ratio | 23.50 | 19.33 | 16.08 | 26.52 | 21.21 | - | Upgrade
|
| EV/EBIT Ratio | 30.83 | 25.37 | 22.82 | 39.49 | 27.09 | - | Upgrade
|
| EV/FCF Ratio | - | - | - | 316.44 | 32.96 | - | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.04 | Upgrade
|
| Debt / EBITDA Ratio | 0.05 | 0.05 | 0.06 | 0.26 | 0.21 | 0.15 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 3.13 | 0.33 | 0.22 | Upgrade
|
| Net Debt / Equity Ratio | -0.69 | -0.69 | -0.76 | -0.79 | -0.82 | -0.45 | Upgrade
|
| Net Debt / EBITDA Ratio | -9.61 | -9.61 | -12.64 | -17.40 | -14.27 | -1.73 | Upgrade
|
| Net Debt / FCF Ratio | - | - | 90.87 | -207.60 | -22.18 | -2.58 | Upgrade
|
| Asset Turnover | - | - | 0.17 | 0.17 | 0.22 | 0.58 | Upgrade
|
| Inventory Turnover | - | - | 1.04 | 1.00 | 0.65 | 0.74 | Upgrade
|
| Quick Ratio | - | - | 44.34 | 35.90 | 35.06 | 11.16 | Upgrade
|
| Current Ratio | - | - | 46.70 | 37.98 | 37.10 | 14.05 | Upgrade
|
| Return on Equity (ROE) | 4.66% | 4.66% | 4.06% | 3.51% | 8.61% | 23.03% | Upgrade
|
| Return on Assets (ROA) | - | - | 2.56% | 1.81% | 4.02% | 14.34% | Upgrade
|
| Return on Invested Capital (ROIC) | 15.16% | 17.04% | 16.41% | 13.28% | 21.61% | 36.27% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | 4.20% | 3.00% | 4.40% | 21.30% | Upgrade
|
| Earnings Yield | 1.92% | 2.20% | 2.33% | 1.79% | 2.81% | - | Upgrade
|
| FCF Yield | - | - | -0.48% | 0.19% | 1.82% | - | Upgrade
|
| Dividend Yield | 1.33% | - | 1.85% | 1.04% | 3.81% | - | Upgrade
|
| Payout Ratio | - | - | 78.18% | 209.31% | 151.70% | - | Upgrade
|
| Buyback Yield / Dilution | 0.27% | 0.27% | -0.30% | -5.70% | -25.24% | -0.46% | Upgrade
|
| Total Shareholder Return | 1.59% | 0.27% | 1.55% | -4.66% | -21.43% | -0.46% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.